Cargando…

Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling

Secondary hyperparathyroidism and abnormalities in tryptophan (TRP) metabolism are commonly observed in chronic kidney disease (CKD). The present study aimed to establish potential interactions between endogenous parathyroid hormone (PTH) and activation of the bone kynurenine (KYN) pathway in relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlak, Krystyna, Sieklucka, Beata, Pawlak, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234704/ https://www.ncbi.nlm.nih.gov/pubmed/34207309 http://dx.doi.org/10.3390/ijms22126563

Ejemplares similares

Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401
por: Mor, Adrian, et al.
Publicado: (2020)

Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss
por: Tawfeek, Hesham, et al.
Publicado: (2010)

Antagonizing microRNA‐19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice
por: Taipaleenmäki, Hanna, et al.
Publicado: (2022)

Vitamin K-Dependent Carboxylation of Osteocalcin in Bone—Ally or Adversary of Bone Mineral Status in Rats with Experimental Chronic Kidney Disease?
por: Ziemińska, Marta, et al.
Publicado: (2022)

Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH
por: Vavanikunnel, Janina, et al.
Publicado: (2022)

FGF2 crosstalk with Wnt signaling in mediating the anabolic action of PTH on bone formation
por: Xiao, Liping, et al.
Publicado: (2018)

Cyclooxygenase-2 Suppresses the Anabolic Response to PTH Infusion in Mice
por: Choudhary, Shilpa, et al.
Publicado: (2015)

Anabolic actions of PTH in murine models: two decades of insights
por: Zweifler, Laura E., et al.
Publicado: (2021)

Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment
por: Fowler, Tristan W., et al.
Publicado: (2012)

Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease—Apart or Together?
por: Ziemińska, Marta, et al.
Publicado: (2021)

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
por: Noda, Hiroshi, et al.
Publicado: (2020)

MMP14 cleaves PTH1R in the chondrocyte-derived osteoblast lineage, curbing signaling intensity for proper bone anabolism
por: Chu, Tsz Long, et al.
Publicado: (2023)

Interactome of PTH-Regulated miRNAs and Their Predicted Target Genes for Investigating the Epigenetic Effects of PTH (1–34) in Bone Metabolism
por: Vrščaj, Lucija Ana, et al.
Publicado: (2022)

Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1–34)
por: Elder, Grahame, et al.
Publicado: (2008)

Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
por: O'Brien, Charles A., et al.
Publicado: (2008)

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
por: Generali, D, et al.
Publicado: (2008)

Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients
por: Zuo, Jiao, et al.
Publicado: (2023)

Loss of the PTH/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise
por: Gardinier, Joseph D., et al.
Publicado: (2019)

Modifications in Bone Matrix of Estrogen-Deficient Rats Treated with Intermittent PTH
por: Pacheco-Costa, Rafael, et al.
Publicado: (2015)

SLPI is a critical mediator that controls PTH-induced bone formation
por: Morimoto, Akito, et al.
Publicado: (2021)

The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

SAT-402 Investigating Analogues of Parathyroid Hormone (PTH) and PTH-Related Peptide (PTHrP) to Improve Anabolic: Catabolic Response Ratios Using UMR106-01 Osteocytic Cells
por: Oladapo, Oladipo Posi, et al.
Publicado: (2020)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

PTH Receptor Signaling in Osteocytes Governs Periosteal Bone Formation and Intracortical Remodeling
por: Rhee, Yumie, et al.
Publicado: (2011)

The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH
por: Pacifici, Roberto
Publicado: (2016)

PTH-Induced Bone Regeneration and Vascular Modulation Are Both Dependent on Endothelial Signaling
por: Cohn-Schwartz, Doron, et al.
Publicado: (2022)

Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
por: Medas, Fabio, et al.
Publicado: (2019)

Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo
por: Anour, René, et al.
Publicado: (2012)

PTH 1-34 promoted bone formation by regulating iron metabolism in unloading-induced bone loss
por: Che, Jingmin, et al.
Publicado: (2023)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH
por: St-Arnaud, René, et al.
Publicado: (2022)

Hypocalcemia after thyroidectomy: iPTH levels and iPTH decline are predictive? Retrospective cohort study()
por: Cannizzaro, Matteo Angelo, et al.
Publicado: (2018)

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance
por: Demaret, Tanguy, et al.
Publicado: (2022)

Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
por: Doyle, N., et al.
Publicado: (2017)

Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

A nomogram for predicting osteoarthritis based on serum biomarkers of bone turnover in middle age: A cross-sectional study of PTH and β-CTx
por: Chen, Xueqiang, et al.
Publicado: (2023)

Parathyroid Hormone (PTH)–Induced Bone Gain Is Blunted in SOST Overexpressing and Deficient Mice
por: Kramer, Ina, et al.
Publicado: (2010)

Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT
por: Brouwers, J. E. M., et al.
Publicado: (2009)

MON-534 Reduced PTH Levels in Adolescents with Anorexia Nervosa: Implication for Kidney and Bone
por: Lenherr-Taube, Nina, et al.
Publicado: (2019)

Effect of PTH treatment on bone healing in insufficiency fractures of the pelvis: a systematic review
por: Bovbjerg, Pernille, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7aakffegc9v546pskj041ikm0r